In spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats, we examined tissue and adrenal norepinephrine concentrations, left ventricular (LV) weight, LV weight/body weight ratio (LV/BW), hlndquarter resistance properties, ie, perfusion pressures at maximum dilatation and constriction (PP^,, PPjni,,), and the slope of the methoxamine log dose-PP curve. In series 1, we studied 4-week-old controls (SHR C , WKYJ, sympathectomized rats (SX; SHR D , WKY D ), and SX rats also given prazosin (SXP; SHRnp, WKY,,,). With SX and SXP, adrenal norepinephrine concentrations increased in both strains, but tissue (LV, muscle, kidney) norepinephrine was depleted. At 4 weeks, LV/BW, PPmin, and PP MI were all greater in SHR C than in WKY C . With SX, these differences between strains remained unchanged, but SXP abolished them completely, indicating the importance of blockade of ar-adrenergic receptor stimuli of adrenal origin. In SHR C (but not in WKY C ), there was evidence of reinnervation after 4 weeks of SX. Hence, in series 2, the SXP period was extended to 8 weeks, and we studied SHR C , WKY C , SHR^, and WKY np . Systolic blood pressure was already elevated at 4 weeks in SHR C , and by 35 weeks it was 64 mm Hg greater than in WKY C . At 21 and 35 weeks, LV/BW, PP^,, PP B| ,, and slopes were all greater in SHR C than in WKY C , and the findings suggested greater LV and vascular hypertrophy than at 4 weeks. In SHR^ hypertension, LV hypertrophy and the vascular changes were completely prevented over the entire 35-week observation period. SXP mainly affected SHR and had few effects on WKY rats. The sympathetic nerves and adrenals are probably the sources of a-adrenergic receptor stimulation in young SHR. They account for the development of hypertension and for most of the cardiovascular structural differences between SHR and WKY rats. 12 This could be through increased resting neural activity, trophically induced cardiovascular hypertrophy, or both. Hypertrophy has usually been thought to occur as a consequence of the hypertension, 3 -5 but recent evidence in SHR suggests that it may precede the rise in blood pressure (BP), so that it could play a causal role in the development of hypertension.6 Hypertrophy contributes to the "amplifier" properties of the hypertensive circulation, whereby appropriate stimuli produce greater vascular narrowing and cardiac emptying. If the sympathetic nervous system were the major factor in initiating hypertension in SHR, then whatever the exact mechanism of action, adequate neonatal sympathectomy (SX) should prevent the rise in BP. In previous studies, hypertension has been attenuated by SX but not completely prevented.1011 It follows that other mechanisms are more important or that SX may have been inadequate. Originally, nerve growth factor antiserum (NGFA) was injected for several days after